Paul Herzich
Chief Tech/Sci/R&D Officer at SOLID BIOSCIENCES INC.
Net worth: 51 428 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alexander Cumbo | M | 53 |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 4 years |
| TY Howton | M | 52 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 3 years |
| Ilan Ganot | M | 50 | 11 years | |
| Jonathan Quick | M | - | 5 years | |
| Ian Smith | M | 58 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 4 years |
| Raj Shah | M | 46 | 7 years | |
| Adam Stone | M | 44 | 9 years | |
| Sukumar Nagendran | M | 58 | 6 years | |
| Martin Freed | M | 63 | 6 years | |
| Lynne Sullivan | F | 58 | 9 years | |
| Annie Ganot | F | - | 11 years | |
| Georgia Keresty | M | 62 | 3 years | |
| Clare Khan | M | 72 | 3 years | |
| Marie Payton | F | - | 5 years | |
| Shuli Kulak | M | - | - | |
| Allison Bogosian | F | - | 3 years | |
| Jessie Hanrahan | M | 47 | 2 years | |
| Matthias Hebben | M | - | 5 years | |
| Kevin Tan | M | 46 | 1 years | |
| Michael Inbar | M | - | 3 years | |
| Alison Kessler | F | - | 4 years | |
| Adam Koppel | M | 54 | 2 years | |
| Gabriel Brooks | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Douglas Swirsky | M | 54 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 2 years |
| Stephen DiPalma | M | 66 | 2 years | |
| Richard A. Moscicki | M | 72 | 4 years | |
| Sheila Mikhail | F | 57 |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 2 years |
| Erin Brennan | M | 53 | 1 years | |
| Jenny Marlowe | M | 47 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | 1 years |
| Caitlin Lowie | F | - | 1 years | |
| Sofia Ioannidou | M | 45 | 2 years | |
| Michael Wyzga | M | 69 | 4 years | |
| Josh Grieger | M | - |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 3 years |
| Adi Barzel | M | - | 4 years | |
| Shannon Stone | F | - | 2 years | |
| L. Smith | M | 57 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 years |
| Sandra E. Poole | F | 60 | 1 years | |
| Carl Morris | M | 54 | 8 years | |
| Rhonda L. Stanley | F | 64 |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | 1 years |
| Kenneth Huttner | M | - | 1 years | |
| Brian Stolz | M | 48 | 1 years | |
| Dean A. Falb | M | 63 | - | |
| Emily Cox | F | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 43 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul Herzich
- Personal Network
